ClinicalTrials.Veeva

Menu

Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Hepatocellular Carcinoma

Treatments

Other: Deep-learning based contrast boosting algorithms
Radiation: Low radiation dose CT
Drug: Low contrast dose CT
Drug: Conventional CT (contrast agent)
Radiation: Conventional CT (radiation)

Study type

Interventional

Funder types

Other

Identifiers

NCT04722120
SNUH-2016-2272

Details and patient eligibility

About

The purpose of this study is to investigate the image quality and clinical feasibility of double low-dose liver computed tomography using a deep-learning-based iodine contrast boosting algorithm in participants at high risk for hepatocellular carcinoma.

Full description

The purpose of this study is to investigate the image quality (CNR, subjective inage quality, vessel and lesion conspicuity) and clinical feasibility (rate of lesion detection) of double low-dose liver computed tomography using a deep-learning-based iodine contrast boosting algorithm in participants at high risk for hepatocellular carcinoma.

Enrollment

68 patients

Sex

All

Ages

20 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Liver cirrhosis
  • Tumor marker (aFP, PIVKA) elevation
  • Nodular lesion on USG
  • Received RFA for HCC

Exclusion criteria

  • hypersensitivity at iodine
  • GFR under 30
  • BMI over 30
  • Nursing or pregnant women
  • enrolled the other study

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

68 participants in 2 patient groups

Conventional liver CT
Active Comparator group
Description:
Underwent conventional liver CT on HCC high-risk patient
Treatment:
Drug: Conventional CT (contrast agent)
Radiation: Conventional CT (radiation)
Double low dose CT
Experimental group
Description:
Underwent double low dose liver CT with 30% lower radiation dose and 20% contrast media on HCC high-risk patient
Treatment:
Drug: Low contrast dose CT
Other: Deep-learning based contrast boosting algorithms
Radiation: Low radiation dose CT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems